Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors

Size: px

Start display at page:

Download "Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors"

Cameron McDowell
6 years ago
Views:

1 706915TUB / Tumor BiologyCao et al. research-article2017 Original Article Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors Tumor Biology July 2017: 1 6 The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: journals.sagepub.com/home/tub Hong-Li Cao 1, Zi-Jin Liu 2 and Zheng Chang 3 Abstract Bladder cancer is a neoplasm originated from bladder epithelial cells. The therapy for bladder cancer is so far not satisfactory. In this study, we examined the effects of Cordyceps militaris hot water extracts containing cordycepin on human bladder cells. Cordyceps militaris hot water extracts containing cordycepin was used to treat human T24 bladder carcinoma cells, and we found that Cordyceps militaris hot water extracts containing cordycepin decreased T24 cell survival in a dose-dependent manner, which was seemingly mediated by activation of A3 adenosine receptor and the subsequent inactivation of Akt pathways, resulting in increases in cleaved Caspase-3 and apoptosis. Overexpression of A3 adenosine receptor in T24 cells mimicked the effects of Cordyceps militaris hot water extracts, while A3 adenosine receptor depletion abolished the effects of Cordyceps militaris hot water extracts containing cordycepin. Together, these data suggest that Cordyceps militaris hot water extracts containing cordycepin may be a promising treatment for bladder cancer via A3 adenosine receptor activation. Keywords Bladder cancer, apoptosis, cordycepin, Akt Date received: 14 July 2016; accepted: 31 January 2017 Introduction Adenosine receptor plays a key role in the regulation of cell survival and cell death. Four distinct subtypes of adenosine receptors have been identified in human, and they are A1, A2A, A2B, and A3. 1 Activation of A3 adenosine receptor (A3AR) has been shown to inhibit cancer growth, 2 5 which has been explained by different mechanism. Activation of A3AR induces suppression of downstream protein kinase, Akt, in some types of cancers. 5,6 Inhibition of Akt leads to the inactivation of Lef/Tcf and β-catenin-responsive c-myc and cyclin D1, which in turn suppresses the cell survival. 7 In line with these findings, functional A3AR has been shown to inhibit Akt to enhance susceptibility of cancer cells to apoptosis. 8 Bladder cancer is a malignant tumor with high prevalence. Although patients with bladder cancer can be treated with a combination of surgery and chemotherapy, some cases appear to be very difficult to be cured. Moreover, tumor resistance against chemotherapy has been frequently found with undetermined mechanisms Cordycepin is the major bioactive component of Cordyceps militaris and has been reported to have anticancer, anti-oxidant, and anti-inflammatory effects. 25,26 However, the molecular pathways of its anti-cancer effect in bladder cancer have not been studied. Therefore, in this study, we investigated whether cordycepin from C. militaris hot water extracts (cordycepin-cmhw) may have anti-cancer effects on human bladder carcinoma. 1 Department of Medical Oncology, Shandong Jiaotong Hospital, Jinan, China 2 Department of Orthopaedics, Provincial Hospital affiliated to Shandong University, Jinan, China 3 Department of Urology, General Hospital of Jinan Military Command, Jinan, China Corresponding author: Zheng Chang, Department of Urology, General Hospital of Jinan Military Command, 25 Shifan Road, Jinan , China. zwn722@yeah.net; doctorchangzheng@163.com Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (

2 2 Tumor Biology Materials and methods Study approval All experimental protocols were approved by the Research Bureau of Shandong University. Cell culture and transfection A human BC cell line T24 was purchased from APCC (American Type Culture Collection, Manassas, VA, USA) and has been widely used in BC research. T24 was generated from an 81-year-old female Caucasian 27 and was cultured in in RPMI1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 15% fetal bovine serum (FBS; Sigma-Aldrich, St Louis, MO, USA) in a humidified chamber with 5% CO 2 at 37 C. A3AR and short hairpin small interfering RNA for A3AR (sha3ar) were purchased from GeneCopoeia (Rockville, MD, USA). The transfection was performed with 50 nmol/l plasmids, using Lipofectamine 2000 (Invitrogen). The transfection efficiency was more than 95%, based on expression of a green fluorescent protein (GFP) reporter. Preparation of cordycepin-cmhw Cordycepin was isolated from the mycelium of C. militaris. Briefly, the seed culture of C. militaris was first prepared using Potato Dextrose Agar (PDA) (Nissui Pharmaceutical Co., Ltd., Japan) plate, after which the inoculant was transferred to 200 ml of Potato Dextrose Broth (PDB) medium (Nissui Pharmaceutical Co., Ltd.) and inoculated at 22 C on a rotary shaker incubator at 150 r/min for 7 days. Mycelium of C. militaris was then developed in a jar fermenter containing wheat-based medium consisting of 43.7% wheat, 5% yeast powder, 0.1% CaCO 3, 0.05% MgSO 4, 0.1% NaH 2 PO 4, 0.05% KH 2 PO 4 1% glucose, and 50% H 2 O and inoculated at 22 C for 28 days. The fermenters were dried at 50 C for 24 h, homogenized, and dissolved in water at ratio of 1:5 (w/v); the fermenters/water mixtures were then incubated at 100 C oven for 24 h (CMHW). Cordycepin amounts in CMHW were analyzed by high-performance liquid chromatography. Quantitative polymerase chain reaction Total RNA was extracted from resected tissue specimens or from the cultured cells, using RNeasy kit (Qiagen, Hilden, Germany). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed in duplicates using QuantiTect SYBR Green PCR Kit (Qiagen), with the primers designed by Qiagen. A 2 ΔΔCt method was used to analyze and quantify the transcript levels. Values of gene transcripts were first normalized against housekeeping gene α-tubulin, and then compared to the experimental controls. Cell survival quantification For assay of cell survival, cells were seeded into 24-well plate at 10 4 cells per well and subjected to a Cell-Clock Kit (Biocolor, Carrickfergus, UK), according to the instruction of the manufacturer. Cell-Clock assay is a live cell detection and measurement system that can be employed to monitor the four major phases of the mammalian cell cycle during in vitro culture. The assay uses a redox dye that is imported by cycling cells. Following dye uptake and incubation, a distinct color change occurs within cells, with particular color changes being associated with cells in the G0 G1, S, G2, and M Phases. The number of the cells as well as the ratio of cells within the different phases can be calculated using this assay supplemented by visible evidence from photomicrographs. Experiments were performed three times. Western blot Protein was extracted from the patient specimen or cultured cells by radioimmunoprecipitation assay (RIPA) buffer (Sigma-Aldrich) for Western Blot. The supernatants were collected after centrifugation at 12,000 g at 4 C for 20 min. Protein concentration was determined using bicinchoninic acid (BCA) protein assay, and whole lysates were mixed with 4 sodium dodecyl sulfate (SDS) loading buffer (125 mmol/l Tris HCl, 4% SDS, 20% glycerol, 100 mmol/l dithiothreitol, and 0.2% bromophenol blue) at a ratio of 1:3. Samples were heated at 100 C for 5 min and were separated on SDS-polyacrylamide gels. The separated proteins were then transferred to a polyvinylidene difluoride (PVDF) membrane. The signals were recorded using X-ray film. Primary antibodies for Western Blot are anti-a3ar, anti- Akt, anti-cleaved caspase-3, and anti-α-tubulin (all purchased from Cell Signaling, San Jose, CA, USA). Secondary antibody is horseradish peroxidase (HRP)-conjugated antirabbit (Jackson Labs, Bar Harbor, ME, USA). Images shown in the figure were representative from five repeats. Statistics All statistical analyses were carried out using the SPSS 18.0 statistical software package. All values are depicted as mean ± standard deviation and are considered significant if p < Two-tailed Student s t test was used for comparisons of two groups and one-way analysis f variance (ANOVA) with a Bonferroni correction was used for comparisons of three or more groups. Results Cordycepin-CMHW dose-dependently decreases survival of bladder cancer cells We examined the effects of cordycepin-cmhw on the survival of a human bladder cancer cell line T24. Thus, cordycepin-cmhw was given to cultured T24 cells at a

Cao et al. 3 Figure 1. Cordycepin-CMHW dose-dependently decreases survival of bladder cancer cells. We examined the effects of cordycepin- CMHW on the survival of a human bladder cancer cell line T24.

(a b) Cell survival was then analyzed in a Cell-clock assay, shown by (a) quantification and (b) representative images (N = 5). *p < 0.05. dose of 0, 10, 30, and 90 µg/ml.

images (Figure 1(b)). Moreover, the cells in the activated cell cycle (G1, S and M phases) appeared to decrease.

Cordycepin-CMHW activates A3AR to suppress Akt, resulting in increases in apoptosis of bladder cancer cells Previous studies have shown that cordycepin-cmhw is a ligand for A3AR, the activation of

3 Cao et al. 3 Figure 1. Cordycepin-CMHW dose-dependently decreases survival of bladder cancer cells. We examined the effects of cordycepin- CMHW on the survival of a human bladder cancer cell line T24. Thus, cordycepin-cmhw was given to cultured T24 cells at a dose of 0, 10, 30, and 90 µg/ml. (a b) Cell survival was then analyzed in a Cell-clock assay, shown by (a) quantification and (b) representative images (N = 5). *p < dose of 0, 10, 30, and 90 µg/ml. The cells were then analyzed in a Cell-clock assay, showing that cordycepin- CMHW dose-dependently decreased survival of bladder cancer cells, by quantification (Figure 1(a)) and by representative images (Figure 1(b)). Moreover, the cells in the activated cell cycle (G1, S and M phases) appeared to decrease. These data suggest a cell growth inhibitory effect of cordycepin-cmhw on bladder cancer cells. Cordycepin-CMHW activates A3AR to suppress Akt, resulting in increases in apoptosis of bladder cancer cells Previous studies have shown that cordycepin-cmhw is a ligand for A3AR, the activation of which directly suppresses Akt and increases apoptosis in some type of cells. Thus, we examined whether this mechanism also function in bladder cancer cells. Hence, we analyzed the protein from cordycepin-cmhw-treated T24 cells by Western blot. We found that cordycepin-cmhw dose-dependently activated A3AR in T24 cells, dose-dependently suppressed total Akt, and dose-dependently increased the levels of cleaved caspase-3, a marker for apoptosis (Figure 2). These data confirm that the mechanism found in other cell type also function in bladder cancer cells, in which cordycepin-cmhw may activate A3AR to suppress Akt, resulting in increases in apoptosis of bladder cancer cells. A3AR overexpression mimics the effects of Cordycepin-CMHW on bladder cancer cells We then examined whether the effects of cordycepin- CMHW on the survival of bladder cancer cells were Figure 2. Cordycepin-CMHW activates A3AR to suppress Akt, resulting in increases in apoptosis of bladder cancer cells. We analyzed the A3AR, Akt, and cleaved caspase-3 protein from cordycepin-cmhw-treated T24 cells by Western blot, shown by representative blots (N = 5). exactly through A3AR. Thus, T24 cells were transfected with either an A3AR-overexpressing plasmid or a plasmid carrying short hairpin RNA (shrna) for A3AR. Transfection of T24 cells with a plasmid carrying a scrambled sequence was used as a control. First, the modulation of A3AR levels in transfected T24 cells was validated by RT-qPCR (Figure 3(a)) and by Western blot (Figure 3(b)). We found that overexpression of A3AR in T24 cells significantly decreased cell survival, while A3AR depletion significantly increased cell survival in the presence of 30 µg/ml cordycepin-cmhw, as a baseline challenge to the cells, shown by quantification (Figure 3(c)) and by representative images (Figure 3(d)). Moreover, the cells in the

4 Tumor Biology Figure 3. A3AR overexpression mimics the effects of Cordycepin-CMHW on bladder cancer cells.

Transfection of T24 cells with a plasmid carrying a scrambled sequence was used as a control. The modulation of A3AR levels in transfected T24 cells was validated by (a) RT-qPCR, and (b) Western blot.

activated cell cycle (G1, S, and M phases) appeared to increase in A3AR-depleted cells and to decrease in A3ARoverexpressing cells (Figure 3(d)).

4 4 Tumor Biology Figure 3. A3AR overexpression mimics the effects of Cordycepin-CMHW on bladder cancer cells. (a b) T24 cells were transfected with either an A3AR-overexpressing plasmid, or a plasmid carrying shrna for A3AR. Transfection of T24 cells with a plasmid carrying a scrambled sequence was used as a control. The modulation of A3AR levels in transfected T24 cells was validated by (a) RT-qPCR, and (b) Western blot. (c d) Cell survival was then analyzed in a Cell-clock assay, shown by (c) quantification and by (d) representative images (N = 5). *p < activated cell cycle (G1, S, and M phases) appeared to increase in A3AR-depleted cells and to decrease in A3ARoverexpressing cells (Figure 3(d)). These data suggest that A3AR overexpression mimics the effects of Cordycepin- CMHW on bladder cancer cells. A3AR overexpression suppresses Akt and increases apoptosis of bladder cancer cells Next, we examined the effects of A3AR modulation on Akt and apoptosis by Western blot. We found that A3AR overexpression suppressed Akt and increased the levels of cleaved caspase-3, while A3AR depletion increased Akt and decreased the levels of cleaved caspase-3 in bladder cancer cells (Figure 4). Together, here we demonstrate that cordycepin-cmhw may be a promising treatment for bladder cancer via A3AR/Akt/Caspase-3 (Figure 5). Discussion A3AR is known to regulate cell survival and cell death. In line with this notion, A3AR has been reported to be highly

5 Cao et al. 5 Figure 4. A3AR overexpression suppresses Akt and increases apoptosis of bladder cancer cells. We examined the effects of A3AR modulation on Akt and cleaved caspase-3 by Western blot, shown by representative blots (N = 5). studies have shown that cordycepin has a potential to inhibit cell proliferation in human bladder carcinoma and found that the molecular pathways of its anti-cancer effect appear to be through the inhibition of cell proliferation and the promotion of cell apoptosis. 5,6 Interestingly, those studies have shown that cordycepin binds the A3AR to activate G protein to inhibit cyclic adenosine monophosphate (camp) formation, to decrease glycogen synthase kinase-3beta/beta-catenin activation, and to suppress cyclin D1 and c-myc expression. Moreover, there are evidence showing that cordycepin may induce cell apoptosis via binding the DR3 receptor which consequently activates caspase-8 and caspase Here, we show that these mechanisms also function in bladder cancer cells. Taken together, cordycepin may be used as a natural medicine for treating bladder cancer, as it can not only control tumor cell proliferation but also induce cancer cell apoptosis. Declaration of conflicting interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding The author(s) received no financial support for the research, authorship, and/or publication of this article. Figure 5. Schematic of the model. Cordycepin-CMHW activates A3AR to suppress Akt, resulting in increases in Caspase-3 and apoptosis in bladder cancer cells. expressed in many tumors. Since the activation of A3AR appears to be detrimental to tumor cell survival, possibly through Akt5 signaling, A3AR activation may be a compensation for control the outgrowth of the tumor mass. Apoptosis has been demonstrated as a mechanism of anti-cancer activity triggers by A3AR. For example, A3AR agonists have been reported to inhibit tumor cell growth and induce cancer cell apoptosis. Here, treated with the cordycepin-cmhw, T24 cells underwent apoptosis, consistent with previous reports elsewhere. Caspases are a family of protease enzymes, which play essential roles in the processes of apoptosis. Specifically, the initiator caspase-8 and caspase-9 motivate the executioner caspase-3 via cleavage for activation, leading to the proteolysis of poly(adp-ribose) polymerase (PARP) and apoptosis through impairment of DNA repair. Here, we show that treatment of T24 cells with cordycepin-cmhw induced caspase-3 activation to enhance apoptosis. The C. militaris is a critical deck for natural drugs to revitalize the various physiological processes. Cordycepin is a major bioactive component in C. militaris. Previous References 1. Snyder SH. Adenosine receptors. Knockouts anxious for new therapy. Nature 1997; 388: Otsuki T, Kanno T, Fujita Y, et al. A3 adenosine receptormediated p53-dependent apoptosis in lu-65 human lung cancer cells. Cell Physiol Biochem 2012; 30: Kim H, Kang JW, Lee S, et al. A3 adenosine receptor antagonist, truncated Thio-CL-IB-MECA, induces apoptosis in T24 human bladder cancer cells. Anticancer Res 2010; 30: Fishman P, Bar-Yehuda S, Ardon E, et al. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 2003; 23: Fishman P, Bar-Yehuda S, Madi L, et al. A3 adenosine receptor as a target for cancer therapy. Anticancer Drugs 2002; 13: Kim SJ, Min HY, Chung HJ, et al. Inhibition of cell proliferation through cell cycle arrest and apoptosis by Thio-CL- IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Cancer Lett 2008; 264: Chen S, Guttridge DC, You Z, et al. Wnt-1 signaling inhibits apoptosis by activating beta-catenin/t cell factor-mediated transcription. J Cell Biol 2001; 152: Parcellier A, Tintignac LA, Zhuravleva E, et al. PKB and the mitochondria: AKTing on apoptosis. Cell Signal 2008; 20: Sun DK, Wang JM, Zhang P, et al. MicroRNA-138 regulates metastatic potential of bladder cancer through ZEB2. Cell Physiol Biochem 2015; 37:

6 6 Tumor Biology 10. Gong Z, Xu H, Su Y, et al. Establishment of a novel bladder cancer xenograft model in humanized immunodeficient mice. Cell Physiol Biochem 2015; 37: Zhan Y, Liu Y, Lin J, et al. Synthetic Tet-inducible artificial micrornas targeting β-catenin or HIF-1α inhibit malignant phenotypes of bladder cancer cells T24 and Sci Rep 2015; 5: Qiu M, Chen L, Tan G, et al. A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells. Sci Rep 2015; 5: Tan M, Gong H, Wang J, et al. SENP2 regulates MMP13 expression in a bladder cancer cell line through sumoylation of TBL1/TBLR1. Sci Rep 2015; 5: Deng X, Yang X, Cheng Y, et al. GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy. Sci Rep 2015; 5: Zhuang J, Lu Q, Shen B, et al. TGFβ1 secreted by cancerassociated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncrna-zeb2nat. Sci Rep 2015; 5: Xiao X, Ma G, Li S, et al. Functional POR A503V is associated with the risk of bladder cancer in a Chinese population. Sci Rep 2015; 5: Liu Q, Zhang C, Ding X, et al. Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the feedback system control (FSC) platform. Sci Rep 2015; 5: Aine M, Eriksson P, Liedberg F, et al. Biological determinants of bladder cancer gene expression subtypes. Sci Rep 2015; 5: Ye Z, Hu J, Song X, et al. A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: a prospective, randomized and multi-center study. Sci Rep 2015; 5: Du M, Shi D, Yuan L, et al. Circulating mir-497 and mir- 663b in plasma are potential novel biomarkers for bladder cancer. Sci Rep 2015; 5: Li S, Li L, Zeng Q, et al. Characterization and noninvasive diagnosis of bladder cancer with serum surface enhanced Raman spectroscopy and genetic algorithms. Sci Rep 2015; 5: Chen F, Li Q, Yu Y, et al. Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis. Sci Rep 2015; 5: Wu W, Tong Y, Zhao Q, et al. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep 2015; 5: Chen X, Xie W, Gu P, et al. Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation. Sci Rep 2015; 5: Nakamura K, Shinozuka K and Yoshikawa N. Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis. J Pharmacol Sci 2015; 127: Tuli HS, Sharma AK, Sandhu SS, et al. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci 2013; 93: Bubenik J, Baresova M, Viklicky V, et al. Established cell line of urinary bladder carcinoma (T24) containing tumourspecific antigen. Int J Cancer 1973; 11: Tian X, Li Y, Shen Y, et al. Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin. Oncol Lett 2015; 10:

Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases

Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,